Insider Buying: Hyperion DeFi (NASDAQ:HYPD) Director Purchases $187,028.60 in Stock

Hyperion DeFi, Inc. (NASDAQ:HYPD) Director Happy David Walters acquired 61,930 shares of the business’s stock in a transaction dated Wednesday, December 17th. The stock was acquired at an average cost of $3.02 per share, with a total value of $187,028.60. Following the completion of the transaction, the director owned 111,930 shares of the company’s stock, valued at approximately $338,028.60. The trade was a 123.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Hyperion DeFi Stock Performance

Shares of HYPD stock traded up $0.67 during trading on Friday, reaching $3.67. 393,434 shares of the company’s stock were exchanged, compared to its average volume of 276,843. Hyperion DeFi, Inc. has a twelve month low of $0.85 and a twelve month high of $17.99. The firm’s fifty day moving average price is $5.31 and its 200-day moving average price is $7.51. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $29.98 million, a PE ratio of -0.91 and a beta of 2.80.

Hyperion DeFi (NASDAQ:HYPD) last announced its quarterly earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. Hyperion DeFi had a negative return on equity of 119.59% and a negative net margin of 62,238.41%.The business had revenue of $0.36 million during the quarter. As a group, sell-side analysts anticipate that Hyperion DeFi, Inc. will post -41.6 EPS for the current year.

Analysts Set New Price Targets

HYPD has been the subject of several research reports. Cantor Fitzgerald initiated coverage on shares of Hyperion DeFi in a research report on Tuesday. They set an “overweight” rating and a $4.00 price objective for the company. Wall Street Zen raised Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperion DeFi in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Hyperion DeFi has a consensus rating of “Hold” and a consensus price target of $3.00.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.